Nabilone
PPA
Simon Ducharme, MDSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the PPA cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLORTAUCIPIR Mayo Clinic | Phase 4 | BBB |
PITTSBURGH COMPOUND B UNLABELLED Mayo Clinic | Phase 1 | CC |
FLUDEOXYGLUCOSE Mayo Clinic | Phase 1 | CC |
ER-176 Mayo Clinic | D |
Same molecule, other indications
Nabilone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →